G. Chalevelakis

669 total citations
29 papers, 520 citations indexed

About

G. Chalevelakis is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, G. Chalevelakis has authored 29 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in G. Chalevelakis's work include Hemoglobinopathies and Related Disorders (11 papers), Acute Myeloid Leukemia Research (6 papers) and Porphyrin Metabolism and Disorders (6 papers). G. Chalevelakis is often cited by papers focused on Hemoglobinopathies and Related Disorders (11 papers), Acute Myeloid Leukemia Research (6 papers) and Porphyrin Metabolism and Disorders (6 papers). G. Chalevelakis collaborates with scholars based in Greece, United States and United Kingdom. G. Chalevelakis's co-authors include D. J. Weatherall, J. B. Clegg, Argyris Michalopoulos, Matthew E. Falagas, Petros I. Rafailidis, Aristea Velegraki, Manousos E. Kambouris, N.J. Legakis, S. Raptis and C. Gardikas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, British Journal of Haematology and Journal of Clinical Pathology.

In The Last Decade

G. Chalevelakis

29 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Chalevelakis Greece 13 150 143 132 120 100 29 520
Mona Wassef Egypt 12 71 0.5× 80 0.6× 95 0.7× 51 0.4× 86 0.9× 36 410
Dimitris A. Papanastasiou Greece 14 126 0.8× 6 0.0× 117 0.9× 192 1.6× 48 0.5× 27 493
Hye Ryun Lee South Korea 12 45 0.3× 5 0.0× 89 0.7× 60 0.5× 75 0.8× 45 397
Valeriu Moldovan Romania 12 36 0.2× 10 0.1× 63 0.5× 40 0.3× 146 1.5× 30 401
Estela Trebicka United States 9 100 0.7× 11 0.1× 195 1.5× 41 0.3× 99 1.0× 11 426
Marc J. Schultz Netherlands 10 6 0.0× 41 0.3× 28 0.2× 132 1.1× 174 1.7× 11 461
Kenichiro Shimizu Japan 13 12 0.1× 29 0.2× 13 0.1× 119 1.0× 167 1.7× 40 532
Andreas M. Ganzoni Switzerland 10 272 1.8× 5 0.0× 341 2.6× 22 0.2× 88 0.9× 33 711
Katsuyuki Kito Japan 9 19 0.1× 9 0.1× 30 0.2× 64 0.5× 194 1.9× 21 402
H.‐J. Lv China 12 6 0.0× 42 0.3× 55 0.4× 71 0.6× 88 0.9× 88 564

Countries citing papers authored by G. Chalevelakis

Since Specialization
Citations

This map shows the geographic impact of G. Chalevelakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Chalevelakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Chalevelakis more than expected).

Fields of papers citing papers by G. Chalevelakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Chalevelakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Chalevelakis. The network helps show where G. Chalevelakis may publish in the future.

Co-authorship network of co-authors of G. Chalevelakis

This figure shows the co-authorship network connecting the top 25 collaborators of G. Chalevelakis. A scholar is included among the top collaborators of G. Chalevelakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Chalevelakis. G. Chalevelakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michalopoulos, Argyris, et al.. (2009). Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. Clinical Microbiology and Infection. 16(2). 184–186. 151 indexed citations
2.
Chalevelakis, G., et al.. (2008). Different Intrafamilial Clinical Presentation of FMF Mutation Carriers. Genetic Testing. 12(1). 125–127. 2 indexed citations
3.
Velegraki, Aristea, et al.. (1999). Rapid extraction of fungal DNA from clinical samples for PCR amplification. Medical Mycology. 37(1). 69–73. 43 indexed citations
4.
Ladas, Spiros D., et al.. (1998). Pancreatic tuberculosis in non-immunocompromised patients. European Journal of Gastroenterology & Hepatology. 10(11). 973–976. 35 indexed citations
5.
Legakis, Ioannis, et al.. (1998). Dissociation of ACTH, β-Endorphin and Cortisol in Graded Sepsis. Hormone and Metabolic Research. 30(9). 570–574. 12 indexed citations
6.
Chalevelakis, G., T. Economopoulos, Μaria Κoffa, et al.. (1997). Codon 12 ras mutations in patients with myelodysplastic syndrome: incidence and prognostic value. Annals of Hematology. 74(1). 11–14. 19 indexed citations
7.
Chalevelakis, G., T. Economopoulos, Μaria Κoffa, et al.. (1995). Ras mutations in patients with myelodysplastic syndrome: Incidence and prognostic value. National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation). 4 indexed citations
8.
Chalevelakis, G., et al.. (1995). δ‐Aminolaevulinic acid dehydratase as an index of lead toxicity. Time for a reappraisal?. European Journal of Clinical Investigation. 25(1). 53–58. 10 indexed citations
9.
Economopoulos, T., E. Papageorgiou, N. Stathakis, et al.. (1992). Treatment of myelodysplastic syndromes with human granulocytic‐macrophage colony stimulating factor (GM‐CSF) or GM‐CSF combined with low‐dose cytosine arabinoside. European Journal Of Haematology. 49(3). 138–142. 5 indexed citations
10.
Chalevelakis, G., et al.. (1991). Effect of starvation and phenobarbital on the activity of liver uroporphyrinogen synthetase. Annales de biologie clinique. 49(7). 401–403. 3 indexed citations
11.
Singounas, E., et al.. (1991). Paraplegia in a pregnant thalassemic woman due to extramedullary hematopoiesis: Successful management with transfusions. Surgical Neurology. 36(3). 210–215. 34 indexed citations
12.
Chalevelakis, G., et al.. (1991). Globin chain synthesis in myelodysplastic syndromes.. Journal of Clinical Pathology. 44(2). 134–138. 6 indexed citations
13.
Economopoulos, Theofanis, J. Economidou, E. Papageorgiou, et al.. (1989). Monoclonal gammopathy in chronic myeloproliferative disorders. Annals of Hematology. 58(1). 7–9. 13 indexed citations
14.
Philippou, Αnastassios, A. Gouliamos, A. Kalovidouris, et al.. (1989). Atypical location of extramedullary hematopoietic masses in thalassemia.. PubMed. 29(6). 295–6. 13 indexed citations
15.
Chalevelakis, G., et al.. (1977). A New Approach to the Diagnosis of <i>β</i>°-Thalassaemia. Acta Haematologica. 58(4). 217–228. 2 indexed citations
16.
Chalevelakis, G., et al.. (1977). Erythrocyte <i>δ</i>-Aminolaevulinic Acid Dehydratase, Urinary Porphyrins and Porphyrin Precursors in Iron Deficiency Anaemia. Acta Haematologica. 57(5). 305–309. 7 indexed citations
17.
Chalevelakis, G., J. B. Clegg, & D. J. Weatherall. (1976). Globin Synthesis in Normal Human Bone Marrow. British Journal of Haematology. 34(4). 535–557. 20 indexed citations
18.
Chalevelakis, G., J. B. Clegg, & D. J. Weatherall. (1975). Imbalanced globin chain synthesis in heterozygous beta-thalassemic bone marrow.. Proceedings of the National Academy of Sciences. 72(10). 3853–3857. 57 indexed citations
19.
Chalevelakis, G., et al.. (1974). Erythrocyte δ‐Aminolaevulinic Acid Dehydratase in Homozygous b‐Thalassaemia. Scandinavian Journal of Haematology. 12(2). 81–84. 2 indexed citations
20.
Chalevelakis, G., et al.. (1972). Erythrocyte Content of Free Protoporphyrin in Thalassaemic Syndromes. Acta Haematologica. 47(3). 164–167. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona Wassef Breakdown of academic impact, for papers by Dimitris A. Papanastasiou Breakdown of academic impact, for papers by Hye Ryun Lee Breakdown of academic impact, for papers by Valeriu Moldovan Breakdown of academic impact, for papers by Estela Trebicka Breakdown of academic impact, for papers by Marc J. Schultz Breakdown of academic impact, for papers by Kenichiro Shimizu Breakdown of academic impact, for papers by Andreas M. Ganzoni Breakdown of academic impact, for papers by Katsuyuki Kito Breakdown of academic impact, for papers by H.‐J. Lv
Rankless by CCL
2026